Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Evonik, Higuchi Announce New Joint Laboratory | Contract Pharma
Breaking News

Evonik, Higuchi Announce New Joint Laboratory

Will provide local formulators with hands‑on access to Evonik’s EUDRAGIT polymers and broader system solutions expertise.

Evonik Industries AG and Higuchi Inc., a Japanese pharmaceutical trading company, will open a joint laboratory in Yokohama, Japan, aimed at supporting drug formulators working on oral solid-dosage products.

The facility, called the Open Pharma Lab, is scheduled to open May 1, 2026, and will give local formulators access to Evonik’s EUDRAGIT polymer excipients and related formulation support. The opening expands Evonik’s regional innovation footprint in Asia as demand rises for oral dosage forms designed around patient use and controlled drug release.

Guido Skudlarek, head of Evonik’s Health Care business line, said the lab is intended to help Japanese customers with formulation development using EUDRAGIT-based systems.

EUDRAGIT is a family of methacrylate-based polymer excipients used in oral drug delivery, including enteric and controlled-release applications. Evonik said its offering combines materials supply with formulation and application support for pharmaceutical developers.

The Yokohama lab will provide collaborative formulation support and technical services tailored to customer projects, drawing on Evonik’s global drug-delivery expertise. The companies said the facility is designed to make Evonik’s excipient technology and support services more accessible to formulators in Japan.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters